About us

Fifteen coders and analysts with years of experience
Fifteen coders and analysts with years of experience

European Med Tech and IVD Reimbursement Consulting Ltd. (MTRC), is a provider of European reimbursement analyses, strategies and education in market access for the Med Tech and In-Vitro Diagnostic (IVD) industry.

The company is founded by Oleg Borisenko, MD, PhD, who has 13 years of experience in health economics, policy and reimbursement for medical devices and IVDs in Europe. Prior to establishing MTRC, Oleg led market access and health economic activities at Synergus AB, the European Med Tech consultancy.

The scope of our services covers 19 European countries

The scope of our services covers 19 European countries, including Austria, Belgium, Czech Republic, Denmark, England, Finland, France, Germany, Hungary, Italy, the Netherlands, Norway, Poland, Romania, Russia, Spain, Sweden, Switzerland and Turkey.

Our team includes several experienced clinical coders and reimbursement analysts, and is complemented by affiliated senior reimbursement consultants from different major countries. Our analysts have an in-depth understanding of the coding and reimbursement landscape and processes in individual countries. Our analysts speak French, German, Italian, Turkish, Russian, Polish languages. We also have on-demand access to native speakers - specialists in health care systems in other key regions of Europe (Scandinavia, the Netherlands, Eastern European countries). 

Our core services include reimbursement analysis, development of reimbursement strategy and providing education in market access. We work across all settings: hospital, day case and ambulatory. We also cover all types of medical technologies, including hospital and ambulatory devices, in-vitro diagnostic tests, medical aids (for home use), and capital equipment. 

Typically, clients seek our help, when they need support in multiple European countries at the same time. While there are many country-specific consultancies in Europe (e.g. focused on the UK or DACH areas only), very few can provide simultaneous support in multiple markets. Among Pan-European consultancies, MTRC has the broadest geographical coverage and proven track record working with key industry players. 

Meet the founder

Oleg Borisenko

Oleg is the Founder and CEO of the MTRC

Oleg has thirteen years of experience in the field. His previous positions include Director of Market Access and Health Economics at Synergus AB and Executive Director of ISPOR Russia Chapter 

During the course of his professional career, Oleg has supervised several hundreds of projects, including reimbursement mappings and strategies, value dossiers, systematic literature reviews, health economic models and within-trial economic evaluations. Oleg has the unique asset of combining both a high-level understanding of a broad range of topics and in-depth knowledge and hands-on experience of major market access-related activities

In the past, Oleg was an active contributor to both the Cochrane Acute Respiratory Infections and Effective Practice and the Organization of Health Care Review Groups. Currently, he is a member of the editorial board of “Journal of Medical Economics” (Informa). Oleg is also an active member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), the Patient Classification System International (PCSI) and the Swedish Health Economics Association (SHEA)

From December 2014 Oleg also holds the position of Affiliated Researcher at the Department of Learning, Informatics, Management and Ethics at the Karolinska Institute in Stockholm, where he is involved in studies aimed at improving the Swedish health care system

MTRC developed the first Youtube channel dedicated to market access for medical devices, in-vitro diagnostic tests, and e-health solutions, “Market Access Insider”

  • The channel includes interviews with decision-makers, researchers, consultants, physicians and patient representatives on the topics of the payment system, health insurance, reimbursement pathways, health technology assessment and others in European countries
  • The channel includes interviews with experts from the Czech Republic, France, Germany, Italy, the Netherlands, and Spain
  • Subscribe to the channel not to miss information about new programs

Our publications

O Borisenko, J Müller-Ehmsen, JA Lindenfeld, E Rafflenbeul, C Hamm. An early analysis of cost-utility of baroreflex activation therapy in advanced chronic heart failure in Germany. BMC Cardiovascular Disorders, 2018. 18:163.

Veličković VM, Borisenko O, Svensson M, Spelman T, Siebert U. Congenital heart defect repair with ADAPT tissue engineered pericardium scaffold: An early-stage health economic model. PLoS One. 2018 Sep 27;13(9):e0204643.

Borisenko O,  Lukyanov V,  Ahmed A.R. Cost-utility analysis of bariatric surgery. Br J Surg. 2018 Apr 17. doi: 10.1002/bjs.10857.

Borisenko O, Adam D, Funch-Jensen P, Ahmed R Ahmed, Zhang R, Colpan Z, Hedenbro J. Bariatric surgery can lead to net cost savings to health care systems: results from a comprehensive European decision analytic model. Obes Surg. 2015 Sep;25(9):1559-68.

Borisenko O, Beige J, Lovett EG, Hoppe UC, Bjessmo S. Cost-Effectiveness of Barostim Therapy for the Treatment of Resistant Hypertension in European Settings. J Hypertens. 2014 Mar;32(3):681-92.

Borisenko O, Colpan Z, Dillemans B, Funch-Jensen P, Hedenbro J, Ahmed R Ahmed. Clinical Indications, Utilization and Funding of Bariatric Surgery in Europe. Obes Surg. 2015 Aug;25(8):1408-16.